Arkolith/Insider Trading/CRSP/Form 4

Kulkarni Samarth

Chief Executive Officer, DirectorCRISPR Therapeutics AG (CRSP) · full profile →Form 4 · filed Jan 22, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5.2M
Net Open-Market Flow
-$5.2M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 22, 2026Sell(S)60K$60.23$3.6M134K
Jan 20, 2026Sell(S)21K$51.61$1.1M203K
Jan 20, 2026Sell(S)9K$52.10$446K194K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-019733) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML